<DOC>
	<DOC>NCT01684540</DOC>
	<brief_summary>This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Rhinitis Nasal Spray. In addition the effectiveness and safety shall be compared to a Sinupret forte. The patient applies Ectoin® Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.</brief_summary>
	<brief_title>Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Female or male individuals ≥ 18 years Patients with acute Rhinosinusitis which are treated with Ectoin® Rhinitis Nasal Spray or Sinupret forte during the observational period Contra indications according to the label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01</keyword>
</DOC>